PITTSBURGH, July 3 /PRNewswire/ -- MED3OOO Group, Inc. (MED3OOO), a national leader in healthcare management and technology products and services for providers and employers, has entered into a partnership arrangement with Mitsui & Co. (USA), Inc., a wholly owned subsidiary of Mitsui & Co., Ltd. (Mitsui). The agreement with Mitsui will provide MED3OOO with opportunities to expand its vision of being a global "premier strategic operations partner" for those involved in the delivery and financing of healthcare. With this business arrangement, Mitsui will gain a minority ownership position in MED3OOO. In addition, both companies will develop an executive exchange program in order to share information, develop global healthcare strategies to improve the health of populations, and make additional investments within and outside the United States for expanding product and service offerings.
"We believe there is great potential for MED3OOO and Mitsui to develop significant footprints in the global healthcare market place," said Bunji Shinoda, Divisional Operating Officer, Mitsui & Co. (USA), Inc., Consumer Service and Business Development Division. "This is an excellent investment and knowledge sharing opportunity in which both companies can expand product and service offerings, focusing mutual efforts on improving the health and quality of life for the populations we serve."
"MED3OOO has made significant investments in providing advanced products and services focused on improvement in the quality and cost of healthcare in the United States," said Patrick V. Hampson, Chairman and CEO of MED3OOO. "Our partnership with Mitsui combines MED3OOO's experience in healthcare technologies and services with the global reach of Mitsui in countries that may benefit from our ability to improve healthcare delivery. MED3OOO and Mitsui share a unique culture in our desire, not only to expand our mutual businesses, but to do so in a manner that is focused on improving clinical outcomes. Healthcare is a significant part of the global economy. As a Global 150 Company, Mitsui can certainly enhance our abilities and opportunities toward reaching our vision."
MED3OOO, a leader in healthcare management services, information management, and technologies, advances the quality and performance of healthcare delivery for providers and payors across the United States. Focused on the provision of evidence-based management and population health management, MED3OOO empowers over 15,000 physician, hospital, employer, health system, and municipal clients across the United States. For more information, please visit http://www.MED3000.com or contact Karla Sartori, MED3OOO Corporate Marketing, at 412-937-8887 or Karla_Sartori@MED3000.com.
About Mitsui & Co. (U.S.A.), Inc.
Mitsui USA is the largest wholly owned subsidiary of Mitsui & Co., Ltd., and has operations in iron and steel products, energy and mineral resources, infrastructure projects, machinery, information business, organic chemicals, plastics and inorganic chemicals, foods and retail, and consumer service and business development, among others. Mitsui USA has nearly 70 group companies in various industries, supported out of its New York headquarters and ten other offices across the United States. For more information, visit http://www.mitsui.com or contact Mitsui & Co. (U.S.A.), Research & Public Affairs Center, at 212-878-4073.
About Mitsui & Co. Ltd.
Mitsui & Co., Ltd., Japan, is one of the world's most diversified and
comprehensive trading, investment, and service enterprises, operating
globally with over 42,000 employees (consolidated), 160 offices in 69
countries, and over 565 subsidiaries and associated companies worldwide.
Mitsui is also involved in various businesses related to the aforementioned
activities, as well as telecommunications and IT, service businesses and
regional development. For more information, visit
http://www.mitsui.co.jp/en/ or contact Mitsui & Co., Ltd., Corporate
Communications Division, at 3-3285-7618.
412-937-8887 ext. 325
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
|SOURCE MED3OOO Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved